Under its new policy, Blue Cross Blue Shield of Massachusetts said Thursday it will continue to cover the meds, known as GLP-1s, in its standard health benefits when theyre prescribed for diabetes but not for obesity
Sergey Terushkin, MD, FACS Looking back, I wish I had started with a medical consultation instead of beginning with an online order
These clinical trial outcomes collectively highlight retatrutides multifaceted efficacy, paving the way for its potential role as a transformative therapy for metabolic diseases
WeightWatchers partnered with Mrs&Mrthe creative, design, and branding agencyto create the new identity that represents who WeightWatchers is today: integrated, intelligent, evidence-based, and always grounded in real-life human care